The optic neuritis treatment trial: a definitive answer and profound impact with unexpected results.
Volpe
Nicholas J
NJ
Scheie Eye Institute, 51 N 39th St, Philadelphia, PA 19104, USA. nickvolp@mail.med.upenn.edu
D000284:Administration, Oral; D005938:Glucocorticoids / Q000627:therapeutic use*; D006801:Humans; D007275:Injections, Intravenous; D008775:Methylprednisolone / Q000627:therapeutic use*; D009103:Multiple Sclerosis / Q000517:prevention & control; D009902:Optic Neuritis / Q000188:drug therapy* / Q000503:physiopathology; D011241:Prednisone / Q000627:therapeutic use*; D012008:Recurrence; D013997:Time Factors; D016896:Treatment Outcome; D014792:Visual Acuity
D005938:Glucocorticoids; D011241:Prednisone; D008775:Methylprednisolone